Sequence information
Variant position: 43 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 442 The length of the canonical sequence.
Location on the sequence:
PGAFMHGAGAASSPVYVPTP
R VPSSVLGLSYLQGGGAGSAS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human PGAFMHGAGAASSPVYVPTPR VPSSVLGLSYLQGGGAGSAS
PGAFMHGAGAASSPVYVPTPR VPSSVLGLSYLQGGGGAAAS
Mouse PGAFMHSAGAASSPVYVPTPR VPSSVLGLSYLQGGGSAAAA
Rat PGAFMHSAGAASSPVYVPTPR VPSSVLGLSYLQGGGSGAAS
Xenopus laevis TGSFMHSATAATSPVYVPTTR VSSMIHSLPYLQ--------
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 442
Transcription factor GATA-4
Literature citations
A novel GATA4 loss-of-function mutation associated with congenital ventricular septal defect.
Yang Y.Q.; Li L.; Wang J.; Liu X.Y.; Chen X.Z.; Zhang W.; Wang X.Z.; Jiang J.Q.; Liu X.; Fang W.Y.;
Pediatr. Cardiol. 33:539-546(2012)
Cited for: VARIANT VSD1 TRP-43; CHARACTERIZATION OF VARIANT VSD1 TRP-43;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.